ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

Nominations sought for NCI consumer liaison group.

January 9, 2004

Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir.

June 23, 2006

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008